Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Treasury Shares (2022 - 2025)

Axsome Therapeutics (AXSM) has disclosed Treasury Shares for 4 consecutive years, with $64281.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 92.91% to $64281.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64281.0 through Dec 2025, down 92.91% year-over-year, with the annual reading at $64281.0 for FY2025, 92.91% down from the prior year.
  • Treasury Shares hit $64281.0 in Q4 2025 for Axsome Therapeutics, down from $1.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.0 million in Q2 2025 to a low of $64281.0 in Q4 2025.
  • Historically, Treasury Shares has averaged $790577.6 across 4 years, with a median of $801218.0 in 2023.
  • Biggest five-year swings in Treasury Shares: grew 17.95% in 2023 and later crashed 92.91% in 2025.
  • Year by year, Treasury Shares stood at $686375.0 in 2022, then grew by 17.16% to $804150.0 in 2023, then increased by 12.78% to $906944.0 in 2024, then plummeted by 92.91% to $64281.0 in 2025.
  • Business Quant data shows Treasury Shares for AXSM at $64281.0 in Q4 2025, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.